ClinicalTrials.gov record
Active, not recruiting Phase 1Phase 2 Interventional Results available

Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I

ClinicalTrials.gov ID: NCT02553460

Public ClinicalTrials.gov record NCT02553460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02553460
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
St. Jude Children's Research Hospital
Other
Enrollment
50 participants

Conditions and interventions

Interventions

  • Asparaginase Erwinia Chrysanthemi Drug
  • Bortezomib Drug
  • Cyclophosphamide Drug
  • Cytarabine Drug
  • Dexamethasone Drug
  • Etoposide Drug
  • ITMHA Drug
  • Leucovorin Calcium Drug
  • Mercaptopurine Drug
  • Methotrexate Drug
  • Mitoxantrone Drug
  • Pegaspargase Drug
  • Vincristine Drug
  • Vorinostat Drug

Drug

Eligibility (public fields only)

Age range
Up to 365 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 28, 2016
Primary completion
May 9, 2022
Completion
Sep 30, 2031
Last update posted
Dec 9, 2025

2016 – 2031

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
Children's Hospital of Orange County Orange California 92868
Lucile Packard Children's Hospital Stanford University Palo Alto California 94304
Children's Hospital and Clinics of Minnesota Minneapolis Minnesota 55404
St. Jude Affiliate-Charlotte Charlotte North Carolina 28204
Cincinnati Children's Hospital Cincinnati Ohio 45229
Oregon Health and Science University Portland Oregon 97239
St. Jude Children's Research Hospital Memphis Tennessee 38105
Children's Hospital of the King's Daughters (CHKD) Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02553460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02553460 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →